AMP 2023
FDA Determination: Data Does Not Support an Excess Mortality Risk for Paclitaxel-Coated Devices
Ramon Varcoe, MBBS, PhD
Prince of Wales Hospital, Sydney, Australia
10/24/2023
In this video recorded at AMP 2023, vascular surgeon Dr. Ramon Varcoe, from Prince of Wales Hospital in Sydney, Australia, talks about his presentation on the new FDA determination that paclitaxel-coated devices do not pose an excess mortality risk in patients and discusses the implications of this decision.
About Us
Vascular Disease Management™ (VDM), the official media partner of the International Symposium on Endovascular Therapy (ISET) and the Amputation Prevention Symposium (AMP), is a peer-reviewed journal that educates readers on the latest advancements in endovascular treatment strategies.
Learn more about ISET and AMP and register for the events here:
Subscribe Now!
Vascular Disease Management Newsletter




